Fracture healing as a post‐natal developmental process: Molecular, spatial, and temporal aspects of its regulation

Fracture healing is a specialized post‐natal repair process that recapitulates aspects of embryological skeletal development. While many of the molecular mechanisms that control cellular differentiation and growth during embryogenesis recur during fracture healing, these processes take place in a post‐natal environment that is unique and distinct from those which exist during embryogenesis. This Prospect Article will highlight a number of central biological processes that are believed to be crucial in the embryonic differentiation and growth of skeletal tissues and review the functional role of these processes during fracture healing. Specific aspects of fracture healing that will be considered in relation to embryological development are: (1) the anatomic structure of the fracture callus as it evolves during healing; (2) the origins of stem cells and morphogenetic signals that facilitate the repair process; (3) the role of the biomechanical environment in controlling cellular differentiation during repair; (4) the role of three key groups of soluble factors, pro‐inflammatory cytokines, the TGF‐β superfamily, and angiogenic factors, during repair; and (5) the relationship of the genetic components that control bone mass and remodeling to the mechanisms that control skeletal tissue repair in response to fracture. J. Cell. Biochem. 88: 873–884, 2003. © 2003 Wiley‐Liss, Inc.

[1]  N. Ferrara,et al.  The biology of vascular endothelial growth factor. , 1997, Endocrine reviews.

[2]  G. Churchill,et al.  Quantitative Trait Loci for Femoral and Lumbar Vertebral Bone Mineral Density in C57BL/6J and C3H/HeJ Inbred Strains of Mice , 2001 .

[3]  K. Takaoka,et al.  Colocalization of Noggin and Bone Morphogenetic Protein‐4 During Fracture Healing , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[4]  N. Wilsman,et al.  Hypertrophic chondrocyte volume and growth rates in avian growth plates. , 1994, Research in veterinary science.

[5]  K. Seibert,et al.  Differential inhibition of fracture healing by non‐selective and cyclooxygenase‐2 selective non‐steroidal anti‐inflammatory drugs , 2003, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[6]  Gabriele Bergers,et al.  MMP-9/Gelatinase B Is a Key Regulator of Growth Plate Angiogenesis and Apoptosis of Hypertrophic Chondrocytes , 1998, Cell.

[7]  C. Hartmann,et al.  Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2 , 2001, Mechanisms of Development.

[8]  R. Kimble,et al.  The Functional Block of TNF but Not of IL‐6 Prevents Bone Loss in Ovariectomized Mice , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[9]  G A Churchill,et al.  Quantitative Trait Loci for Femoral and Lumbar Vertebral Bone Mineral Density in C57BL/6J and C3H/HeJ Inbred Strains of Mice , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[10]  C. Patterson,et al.  Enhanced expression of vascular endothelial growth factor in human SaOS-2 osteoblast-like cells and murine osteoblasts induced by insulin-like growth factor I. , 1996, Endocrinology.

[11]  K. Takaoka,et al.  Transient and localized expression of bone morphogenetic protein 4 messenger RNA during fracture healing , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[12]  Charles A. Rockwood,et al.  Rockwood and Green's Fractures in Adults , 1991 .

[13]  V. Rosen,et al.  Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[14]  S. Mohan,et al.  Gene expression between a congenic strain that contains a quantitative trait locus of high bone density from CAST/EiJ and its wild-type strain C57BL/6J , 2002, Functional & Integrative Genomics.

[15]  S. Mohan,et al.  Genetic variation in bone-regenerative capacity among inbred strains of mice. , 2001, Bone.

[16]  Giuseppe M Peretti,et al.  Recapitulation of signals regulating embryonic bone formation during postnatal growth and in fracture repair , 1998, Mechanisms of Development.

[17]  Thomas A Einhorn,et al.  Differential Temporal Expression of Members of the Transforming Growth Factor β Superfamily During Murine Fracture Healing , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[18]  R J O'Keefe,et al.  The potential role of transforming growth factor beta in fracture healing. , 1998, Clinical orthopaedics and related research.

[19]  N. Takahashi,et al.  Bone Morphogenetic Protein-2 Converts the Differentiation Pathway of C2C12 Myoblasts into the Osteoblast Lineage , 2002 .

[20]  T. Einhorn,et al.  Bone Regeneration: New Findings and Potential Clinical Applications , 2001, The Journal of the American Academy of Orthopaedic Surgeons.

[21]  Y. Iwamoto,et al.  Intramuscular bone induction by human recombinant bone morphogenetic protein-2 with beta-tricalcium phosphate as a carrier: in vivo bone banking for muscle-pedicle autograft , 2002, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.

[22]  N. Ferrara,et al.  Angiogenesis and bone growth. , 2000, Trends in cardiovascular medicine.

[23]  J. Glowacki.  Angiogenesis in fracture repair. , 1998, Clinical orthopaedics and related research.

[24]  H. Reddi.  Interplay between bone morphogenetic proteins and cognate binding proteins in bone and cartilage development: noggin, chordin and DAN , 2000, Arthritis research.

[25]  Pamela F. Jones,et al.  Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis , 1996, Cell.

[26]  S. Papapoulos,et al.  Bone Morphogenetic Proteins Stimulate Angiogenesis through Osteoblast-Derived Vascular Endothelial Growth Factor A. , 2002, Endocrinology.

[27]  M. Longaker,et al.  Hypoxia and VEGF up-regulate BMP-2 mRNA and protein expression in microvascular endothelial cells: implications for fracture healing. , 2002, Plastic and reconstructive surgery.

[28]  C. Chang,et al.  Xenopus GDF6, a new antagonist of noggin and a partner of BMPs. , 1999, Development.

[29]  V. Rosen,et al.  Novel regulators of bone formation: molecular clones and activities. , 1988, Science.

[30]  T. Bauer,et al.  Demineralized bone matrix and native bone morphogenetic protein in orthopaedic surgery. , 2002, Clinical orthopaedics and related research.

[31]  M. Urist,et al.  Bone: Formation by Autoinduction , 1965, Science.

[32]  Theodore Miclau,et al.  Does adult fracture repair recapitulate embryonic skeletal formation? , 1999, Mechanisms of Development.

[33]  S. Bruder,et al.  Osteogenic differentiation of purified, culture‐expanded human mesenchymal stem cells in vitro , 1997, Journal of cellular biochemistry.

[34]  D. Hu,et al.  Molecular aspects of healing in stabilized and non‐stabilized fractures , 2001, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[35]  S. Mohan,et al.  Identification of wound healing/regeneration quantitative trait loci (QTL) at multiple time points that explain seventy percent of variance in (MRL/MpJ and SJL/J) mice F2 population. , 2001, Genome research.

[36]  E B Hunziker,et al.  Physiological mechanisms adopted by chondrocytes in regulating longitudinal bone growth in rats. , 1989, The Journal of physiology.

[37]  Napoleone Ferrara,et al.  VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation , 1999, Nature Medicine.

[38]  Shizhong Xu,et al.  Genetic control of the rate of wound healing in mice , 2001, Heredity.

[39]  L. Donahue,et al.  Postnatal and Pubertal Skeletal Changes Contribute Predominantly to the Differences in Peak Bone Density Between C3H/HeJ and C57BL/6J Mice , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[40]  Yongwon Choi,et al.  Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[41]  A. McMahon,et al.  Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton. , 1998, Science.

[42]  G. Breur,et al.  Linear relationship between the volume of hypertrophic chondrocytes and the rate of longitudinal bone growth in growth plates , 1991, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[43]  T A Einhorn,et al.  Growth Factor Regulation of Fracture Repair , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[44]  H. Redmond,et al.  Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[45]  Richard P Lifton,et al.  High bone density due to a mutation in LDL-receptor-related protein 5. , 2002, The New England journal of medicine.

[46]  V. Rosen,et al.  Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage [published erratum appears in J Cell Biol 1995 Feb;128(4):following 713] , 1994, The Journal of cell biology.

[47]  M. Klagsbrun,et al.  Neuropilin‐1 expression in osteogenic cells: Down‐regulation during differentiation of osteoblasts into osteocytes , 2001, Journal of cellular biochemistry.

[48]  G. Rodan,et al.  Expression and regulation of vascular endothelial growth factor in osteoblasts. , 1995, Clinical orthopaedics and related research.

[49]  R. Thompson,et al.  Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats. , 1994, The Journal of clinical investigation.

[50]  T. Einhorn,et al.  Induction of a neoarthrosis by precisely controlled motion in an experimental mid‐femoral defect , 2002, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[51]  P. Jones,et al.  Phenotypic conversion of cultured mouse embryo cells by aza pyrimidine nucleosides. , 1978, Developmental biology.

[52]  M. Bolander,et al.  Transforming growth factor-beta in the regulation of fracture repair. , 1990, The Orthopedic clinics of North America.

[53]  Mara Riminucci,et al.  Bone Marrow Stromal Stem Cells: Nature, Biology, and Potential Applications , 2001, Stem cells.

[54]  R. Russell,et al.  An interleukin 1 like factor stimulates bone resorption in vitro , 1983, Nature.

[55]  A. Reddi.  Bone Morphogenetic Proteins: From Basic Science to Clinical Applications , 2001, The Journal of bone and joint surgery. American volume.

[56]  Darwin J. Prockop,et al.  In vitro cartilage formation by human adult stem cells from bone marrow stroma defines the sequence of cellular and molecular events during chondrogenesis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[57]  T. Einhorn,et al.  Impaired Intramembranous Bone Formation during Bone Repair in the Absence of Tumor Necrosis Factor-Alpha Signaling , 2001, Cells Tissues Organs.

[58]  R. Marcus,et al.  Peak Bone Mass , 2000, Osteoporosis International.

[59]  Thomas A Einhorn,et al.  Chondrocytes Provide Morphogenic Signals That Selectively Induce Osteogenic Differentiation of Mesenchymal Stem Cells , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[60]  John C. Lee,et al.  Osteogenic protein-1 increases gene expression of vascular endothelial growth factor in primary cultures of fetal rat calvaria cells , 1999, Molecular and Cellular Endocrinology.

[61]  A. Weiland,et al.  Immunolocalization and expression of bone morphogenetic proteins 2 and 4 in fracture healing , 1995, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[62]  R. Rizzoli,et al.  Peak bone mass , 2005, Osteoporosis International.

[63]  T A Einhorn,et al.  The expression of cytokine activity by fracture callus , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[64]  V. Goldberg,et al.  Bone and cartilage formation in diffusion chambers by subcultured cells derived from the periosteum. , 1990, Bone.

[65]  M. Longaker,et al.  Angiogenesis during mandibular distraction osteogenesis. , 1999, Annals of plastic surgery.

[66]  G. Churchill,et al.  Quantitative trait loci for bone density in C57BL/6J and CAST/EiJ inbred mice , 1999, Mammalian Genome.

[67]  T A Einhorn,et al.  Expression of Osteoprotegerin, Receptor Activator of NF‐κB Ligand (Osteoprotegerin Ligand) and Related Proinflammatory Cytokines During Fracture Healing , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.